These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4173030)

  • 21. ANTICOMPLEMENTARY PHENOMENA IN MONOCLONAL HYPERGLOBULINEMIA.
    COOPER RG
    J Lab Clin Med; 1964 Mar; 63():404-15. PubMed ID: 14164494
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis.
    West CD; Winter S; Forristal J; McConville JM; Davis NC
    J Clin Invest; 1967 Apr; 46(4):539-48. PubMed ID: 4164258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation, characterization, and activation of a highly purified factor XI: evidence that a hitherto unrecognized plasma activity participates in the interaction of factors XI and XII.
    Schiffman S; Lee P
    Br J Haematol; 1974 May; 27(1):101-14. PubMed ID: 4137120
    [No Abstract]   [Full Text] [Related]  

  • 24. A chemotactic factor for mononuclear leukocytes.
    Snyderman R; Shin HS; Hausman MH
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):387-90. PubMed ID: 5118450
    [No Abstract]   [Full Text] [Related]  

  • 25. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
    Taylor PA; Fink S; Bing DH; Painter RH
    J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of red cells coated with C4 and C3 subcomponents and production of anti-C4d and anti-C3d.
    Freedman J; Mollison PL
    Vox Sang; 1976 Oct; 31(4):241-57. PubMed ID: 822586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhomogeneity of peripheral lymphocytes. Complement receptors in a portion of human lymphocytes].
    Michlmayr G; Pastner D; Huber H
    Klin Wochenschr; 1970 May; 48(10):634-6. PubMed ID: 4996122
    [No Abstract]   [Full Text] [Related]  

  • 28. Receptor sites for complement on certain human peripheral blood lymphocytes.
    Michlmayr G; Huber H
    J Immunol; 1970 Sep; 105(3):670-6. PubMed ID: 4989556
    [No Abstract]   [Full Text] [Related]  

  • 29. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.
    Carlo JR; Ruddy S; Studer EJ; Conrad DH
    J Immunol; 1979 Aug; 123(2):523-8. PubMed ID: 88474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properdin factor D: characterization of its active site and isolation of the precursor form.
    Fearon DT; Austen KF; Ruddy S
    J Exp Med; 1974 Feb; 139(2):355-66. PubMed ID: 4855753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A theory of lymphocyte blast transformation (LBT) and malignant change based on proteolytic cleavage of trigger peptide: the detendomer.
    Kast RE
    Oncology; 1974; 29(3):249-64. PubMed ID: 4137518
    [No Abstract]   [Full Text] [Related]  

  • 32. Neutral leucocyte proteases and elastase inhibited by plasma alpha 1 -antitrypsin.
    Ohlsson K
    Scand J Clin Lab Invest; 1971 Nov; 28(3):251-3. PubMed ID: 4109213
    [No Abstract]   [Full Text] [Related]  

  • 33. Reactive haemolysis--a distinctive form of red cell lysis.
    Thompson RA; Rowe DS
    Immunology; 1968 May; 14(5):745-62. PubMed ID: 4172980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement as a mediator of inflammation: formation of biologically-active products after interaction of serum complement with endotoxins and antigen-antibody complexes.
    Mergenhagen SE
    J Periodontol; 1970 Apr; 41(4):202-4. PubMed ID: 4191699
    [No Abstract]   [Full Text] [Related]  

  • 35. Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.
    Brade V; Nicholson A; Bitter-Suermann D; Hadding U
    J Immunol; 1974 Dec; 113(6):1735-43. PubMed ID: 4279261
    [No Abstract]   [Full Text] [Related]  

  • 36. Some enzymic properties of human lens esterase I.
    Swanson AA; Truesdale AW
    Invest Ophthalmol; 1974 Jun; 13(6):466-8. PubMed ID: 4208803
    [No Abstract]   [Full Text] [Related]  

  • 37. GUINEA PIG BETA-1C-GLOBULIN: ITS RELATIONSHIP TO THE THIRD COMPONENT OF COMPLEMENT AND ITS ALTERATION FOLLOWING INTERACTION WITH IMMUNE COMPLEXES.
    LINSCOTT WD; COCHRANE CG
    J Immunol; 1964 Dec; 93():972-84. PubMed ID: 14245928
    [No Abstract]   [Full Text] [Related]  

  • 38. STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.
    HAINES AL; LEPOW IH
    J Immunol; 1964 Mar; 92():456-67. PubMed ID: 14128991
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on serum Pi- and C3-polymorphism in Finland.
    Arvilommi H
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 234():Suppl 234:1-50. PubMed ID: 4125697
    [No Abstract]   [Full Text] [Related]  

  • 40. On the recovery of adhesiveness by trypsin-dissociated cells.
    Steinberg MS; Armstrong PB; Granger RE
    J Membr Biol; 1973; 13(2):97-128. PubMed ID: 4205052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.